Professor Bertie Squire

Chair in Clinical Tropical Medicine, Director Centre for Applied Health Research and Delivery (CAHRD)

Areas of interest

Tuberculosis: improving access by the poor to diagnosis and clinical care.  Equity in Health.  Applied Health Research


Studied medicine and immunology at University College London and Cambridge University before professional training in internal medicine, infectious diseases and respiratory medicine at the Royal London Hospital and the Royal Free Hospital. From 1992 to 1995 he was Head of the Department of Medicine, Kamuzu Central Hospital, Lilongwe, Malawi. Since his appointment at LSTM in 1995, Bertie has maintained his research collaboration with the National TB Control Programme in Malawi and has facilitated the transformation of the collaboration into the Malawi-registered Trust for Research on Equity And Community Health (REACH). With his colleagues in Liverpool, Malawi and China he has built up a programme of multi-disciplinary applied health research aimed at providing knowledge for action in making health services for tuberculosis more accessible to poor people in developing countries (including those affected by the HIV pandemic). He holds an appointment in the UK National Health Service as Honorary Consultant in Infectious Diseases and Tropical Medicine at the Royal Liverpool University Hospital and is the immediate past President of the International Union Against Tuberculosis & Lung Disease.

Teaching and Examining

Lectures on TB, HIV, schistomiasis, and ethics and small group teaching on the Liverpool DTM&H and several Masters Courses.  Lectures to many other groups nationally and internationally


Tuberculosis: improving access to services for the poor including diagnosis and clinical care, implementation research for appropriate technology for disease control. Equity in health. Research ethics.

Recently completed, supervised research thesis titles

2016 - PhD - "Improving the management of adults in Malawi receiving treatment regime for turberculosis" (with Dr Geraint Davies)

2015 - PhD - "A pragmatic randomised trial of engaging informal providers in the diagnostic process for TB and HIV in Malawi" (with Dr Brian Faragher)

2014 - PhD - "Improving linkage into HIV care among adults in Blantyre, Malawi" (with Professor David Lalloo& Dr Liz Corbett)

2011 - PhD - "The role of Mycobacterial Antigens in Early Mortality in Patients Treated for TB" (with Professor Munir Pirmohamed)

Research Grants


Award Holder

Funding Body


Value (£ sterling equivalent)

2016 - 2019

SB Squire & I Langley MRC - Philippines Newton Fund Impact assessment of diagnostic tools for multi-drug resistant (MDR) and drug sensitive tuberculosis in the Philippines £300,000

2014 - 2016

SB Squire, T Martineau, K Millington DFID Health and Education Resource Team (in consortium led by Oxford Policy Management) £145,000 (LSTM only)

2014 - 2020

SB Squire with The Union USAID TREAT TB: Technology, Research, Education and Technical Assistance for Tuberculosis Project £493,531 (LSTM only)

2014 - 2015

SB Squire NHS Co-ordinating NW TB Cohort Reviews £10,512

Other relevant expertise, professional memberships etc.

  • 2016 to date: Member of the Strategic and Technical Advisory Group for TB (STAG-TB), World Health Organization (WHO).
  • 2016 to date: Expert Adviser of the National Institute for Health Care Excellence (NICE) Centre for Clinical Practice Committee.
  • 2015: Member of the Independent Steering Committee. Tobacco cessation wihtin TB programmes. A 'real world' solution for countries with a dual burden of disease 2015 - 2019.
  • 2014 to date: Member of the Scientific Working Group for Intervention & Implementation Research UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR).
  • 2012 - 2015: Member of the National Institute for Health and Care Excellence (NICE) Guideline Development for Tuberculosis.
  • 2011 - 2015: Chair of the Trial Steering Committee, TB Fast Track Study (funded by Joint Global Health Trials Initiative - testing the role of urinary LAM in detecting TB in HIV-infected patients).
  • 2010 - 2012: Member of the National Institute for Health and Care Excellence (NICE) Programme Development for Tuberculosis; Hard to Reach Populations.
  • 2010 to date: Chair of the Steering Committee, Health Protection Agency PREDICT Study (role of IGRA tests in predicting progression of latent TB).

Contributions to International Health Policy

International Health policy dialogue and advocacy: I contribute to international health policy and practice through my role as Past President of the International Union Against Tuberculosis and Lung Disease, and my previous positions in Working Group structure of the Global STOP-TB Partnership. I am a formal member of the WHO Strategic and Technical Advisory Group for Tuberculosis (STAG-TB) meetings and the Scientific Working Group (SWG) on Intervention and Implementation Research for the Special Programme for Research and Training in Tropical Diseases (TDR).